Omega Diagnostics Group Plc gets MOH approval for VISITECT® CD4 350 test

> Omega Diagnostics Group Plc (LON: ODX) has reported about Nigerian MOH approval for VISITECT® CD4 350 test.
  • The Nigerian MOH (Federal Ministry of Health) has given its approval to the company to enable the VISITECT® CD4 350 test to be deployed in the country.
  • NASCP (the National AIDS and Sexually Transmitted Infections Control Programme), who co-ordinated a product evaluation in six geopolitical zones in Nigeria, recommended to the MOH for the adoption of the test in the National HIV Control Programme.